Lakefront Biotherapeutics (LKFT) FCF Margin Growth (3y) (2017 - 2026)

Lakefront Biotherapeutics (LKFT) FCF Margin Growth (3y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15,064.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 723.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -1,409.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Lakefront Biotherapeutics 1.85 Bn -1.64 Bn 1.91 Mn -129,945.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -129,945.00
Dec 31, 2025 11,429.00
Mar 31, 2025 31,578.00
Mar 31, 2023 -9,349.00
Dec 31, 2022 1,705.00
Mar 31, 2022 -15,202.00
Jun 30, 2020 18.38 Mn
Mar 31, 2020 55.00
Jun 30, 2019 -5,016.00
Mar 31, 2019 -270,853.00
Dec 31, 2018 -6,075.00
Dec 31, 2017 -3,503.00